Background. Outbreaks of invasive aspergillosis (IA) are believed to be caused by airborne Aspergillus conidia. Few studies have established a correlation between high levels of Aspergillus fumigatus conidia and the appearance of new cases of IA or have demonstrated matching genotypes between clinical isolates and those from the environment.
Invasive aspergillosis (IA) mainly affects severely immunocompromised patients such as those with neutropenia due to hematological and oncological diseases and other entities associated with immunosuppression [1] [2] [3] [4] . In this population, pulmonary invasion is the most common clinical presentation of IA.
IA may also occur in nonimmunocompromised patients, particularly those who have just undergone surgery or those with burns [5] [6] [7] [8] [9] . The disease has also been reported in patients who have undergone major heart surgery (MHS), mainly as case reports or reports on small outbreaks of perioperatively acquired infective endocarditis, which is usually attributed to airborne Aspergillus conidia in operating rooms [8, [10] [11] [12] . However, due to the implementation of air quality regulations requiring high-efficiency particulate air (HEPA) filtration and positive pressure in the air of MHS operating rooms in many countries, these outbreaks have been minimized [13] . IA is rarely acquired during the period following MHS [9] .
Some studies have demonstrated an epidemiological relationship between the presence of Aspergillus in the air and the occurrence of nosocomial IA [14] [15] [16] [17] . However, the demonstration of genotypic identity between Aspergillus fumigatus strains from air and those found in clinical samples is difficult, because environmental samples are rarely taken routinely or only after clinical outbreaks are detected. In addition, molecular genotyping of A. fumigatus remains uncommon.
We describe an outbreak of IA acquired during the post-MHS period and its relationship with high counts of genotypically related Aspergillus in the environment.
MATERIALS AND METHODS

Setting and Description of the MHS Intensive Care Unit
Our institution is a large teaching hospital attending a population of 715 000 inhabitants. The heart surgery division performs 600 MHS interventions per year. The 2 MHS operating rooms have positive pressure and HEPA filters.
The MHS intensive care unit (MHS-ICU) was divided into 3 areas: 1 area in which air is HEPA-filtered with positive pressure and 2 adjacent areas for immediate postoperative care in which the air is regularly filtered (non-HEPA) without positive pressure.
Patients in the MHS-ICU are followed up by a team of specialized anesthetists and cardiovascular surgeons. Infectious diseases specialists perform daily rounds to collaborate in the diagnosis and treatment of infectious complications and in the implementation of preventive measures.
Patients
The outbreak lasted from December 2006 through April 2008. Each patient included was classified according to the probability of having IA following the guidelines of the European Organization for Research and Treatment of Cancer/Mycoses Study Group [18] . According to these criteria, patients with a positive Aspergillus culture were classified as proven IA, probable IA, or colonization. The Aspergillus score of Bouza et al [19] was also applied to these patients. Demographic, clinical, microbiological, and histopathological data were recorded.
Environmental Surveillance
Volumetric air samples from the 3 MHS-ICUs and from the 2 operating rooms are obtained at least once a month for quantitative and qualitative identification of filamentous fungi. Additional samples were also obtained when a suspicious case of Aspergillus infection was detected.
During the study period, we obtained 508 environmental samples from 3 different periods: June-November 2006 (preoutbreak period), December 2006 through April 2008 (outbreak period), and May-October 2008 (post-outbreak period).
Air was sampled using a volumetric sampler (Merck Air Sampler MAS 100; http://www.merck-chemicals.com/pharmaceuticalingredients/mas-100-microbial-air-monitoring-systems/spanish/ c_FMCb.s1OQgYAAAEoFldh9ENU) [11, 20] . Sealed Sabourauddextrose irradiated plates were incubated at 30°C for 5 days. The plates were examined daily to check for fungal growth. Colonies of A. fumigatus growing on the plates were isolated and identified by morphological procedures and stored.
Clinical Samples and Other Diagnostic Procedures
Clinical samples were requested by physicians. All specimens were cultured in fungal media (Sabouraud-dextrose agar with chloramphenicol, brain-heart infusion agar with antibacterial agents, and potato-dextrose agar) and incubated at 30°C for 3 weeks. Molds were identified based on macroscopic and microscopic characteristics according to conventional procedures [21] . Antifungal susceptibility testing was performed on all the isolated clinical strains following the criteria of the Clinical Laboratory Standards Institute. Aspergillus serum galactomannan was determined using the Platelia Aspergillus system (BioRad, Marnes-la-Coquette, France), with a positivity cutoff of $0.5 ng/mL.
Molecular Typing
Available environmental and clinical strains were genotyped according to the short tandem repeats (STRAf ) assay developed by de Valk et al [22] . This approach is based on analysis of 9 short tandem repeat markers that are amplified by means of 3 multiplex polymerase chain reactions.
The number of repeats in each marker was assigned using Fragment Profiler software (version 1.2; GE Healthcare). Typing data were imported into Bionumerics software (version 6.0.1; Applied Maths, Sint-Martens-Latem, Belgium). In line with previous definitions, environmental and clinical isolates were considered matched when genotypes were identical (same allele composition for all 9 markers) or clonally related (genotypes with a total of up to 2 repeats' difference in a single locus) [23] . Due to the highly discriminatory and reproducible results of this method, quality control isolates are not necessary. Further details on the criteria for STRAf are presented by Guinea et al [24] .
Statistical Analysis
Spore counts of A. fumigatus during the 3 periods (preoutbreak, outbreak, and post-outbreak) were compared using the Mann-Whitney U test. The clinical characteristics of the 7 patients with IA are shown in Table 1 . Five patients had pulmonary IA, 1 patient had postsurgical mediastinitis, and 1 patient had both mediastinitis and pulmonary IA. The main underlying conditions included heart transplantation (n 5 3), diabetes mellitus (n 5 2), corticosteroid-dependent asthma (n 5 1), and corticosteroiddependent chronic obstructive pulmonary disease with multiple myeloma (n 5 1). All these patients had a very complicated postsurgical course, which required prolonged mechanical ventilation. Four patients required continuous arteriovenous hemofiltration before the diagnosis of IA, and 3 patients had undergone further surgery, mainly due to hemorrhage. IA was diagnosed 3-72 days after the initial surgical procedure. Six of the 7 patients with IA died (85.7%). Three patients died before receiving optimal therapy: 2 received caspofungin as empirical therapy for invasive candidiasis, and 1 died before antifungal therapy could be started. The 4 remaining patients received combination therapy with voriconazole and caspofungin; only 1 of them survived.
Microbiological Findings and Other Diagnostic Procedures
Diagnostic findings are summarized in Table 2 . Six of the 7 patients with IA had A. fumigatus isolated. Three patients (1, 3, and 7) had a polyfungal infection. Three non-A. fumigatus species were isolated from patient 3 (A. flavus, A. niger, and A. nidulans).
All the strains were susceptible to amphotericin B, voriconazole, itraconazole, posaconazole, and caspofungin, with the exception of the A. flavus strain (patient 1), which was resistant to caspofungin (median inhibitory concentration, .32 lg/mL).
Calcofluor white staining revealed septate hyphae in all the clinical samples. In the 2 patients with mediastinitis, invasion by Aspergillus was also demonstrated in the tissue biopsies. Postmortem examination was not permitted in any of the patients. All but patients 1 and 2 had a positive Aspergillus galactomannan test result in serum ($0.5 ng/mL). The mean value of the Aspergillus score in the 7 patients with IA was 3.4 (range, 2-4).
Thoracic computed tomography scans were performed in 4 patients and revealed pulmonary infiltrates (n 5 1), pleural effusion (n 5 2), and nodular lesions (n 5 2). The chronological distribution of the IA cases and the mean level of A. fumigatus conidia obtained in the MHS-ICU and in the operating rooms are summarized in Figures 1 and 2 and Table 3 . (Figure 2 ). Detection of cases with IA caused by A. fumigatus coincided with abnormally high levels of A. fumigatus conidia in the air of the MHS-ICU. During this period, extensive building work was being performed in the hospital. The building work involved the refurbishment of a day-hospital in the cardiology department, which is located on the same floor, just in front of the main entrance to the MHS-ICU. All recommended control measures were strictly followed. The air conditioning system was shared by both areas. Throughout the study period (6 months before the outbreak, during the outbreak, and 6 months after it), we obtained 508 environmental samples from the MHS-ICU. During the outbreak period, we genotyped 59 environmental isolates (from 30 environmental samples) and 109 clinical isolates (from 35 clinical samples) using STRAf. We found matches between clinical and environmental A. fumigatus genotypes in 3 of the 6 IA cases (patient 1, with mediastinitis, and patients 4 and 6, with invasive pulmonary aspergillosis).
After the last peak of abnormally high airborne conidia levels, the air conditioning system was replaced. HEPA filters were installed in all the rooms of the MHS-ICU. No further cases of IA have been recorded to date.
DISCUSSION
Our study revealed that abnormally high levels of airborne A. fumigatus conidia correlated with new cases of IA, even in patients who were not severely immunocompromised. The demonstration of matches between air and clinical genotypes reinforces the role of environmental air in the acquisition of IA during the period following MHS.
The incidence of IA is increasing in many institutions, and recent publications suggest important shifts in the underlying conditions of patients and in the species of Aspergillus causing the disease [2, [25] [26] [27] . The disease occurs mainly in profoundly immunocompromised neutropenic or nonneutropenic patients [1, 3, 4, [28] [29] [30] . However, IA is increasingly frequent in specific groups of nonimmunocompromised patients, such as patients undergoing major surgery and burn patients with tissue exposed to the environment [1, 7, 8, [31] [32] [33] [34] .
Invasive aspergillosis in patients undergoing MHS has mainly been reported as an intra-operative accident due to deficiencies in the air conditioning of operating rooms leading to isolated cases or outbreaks of infective endocarditis [9, 12] . Postoperative acquisition of IA after MHS occurs mainly in patients undergoing heart transplantation or with severe immunodeficiency, but also-albeit rarely-occurs in noninmunocompromised patients [35] [36] [37] [38] . The most common clinical presentation is invasive pulmonary or wound aspergillosis [38, 39] . However, to the best of our knowledge, neither of the two has been related to high environmental levels of Aspergillus conidia.
The epidemiological link between outbreaks of IA and environmental contamination is relatively strong [11, 17] . Other than this epidemiological evidence, few reports have correlated the increasing concentrations of spores in air with an increasing incidence of IA [40, 41] . However, the weaknesses of those studies include the lack of a reference concentration of Aspergillus in air, making it impossible to distinguish normal from abnormal or ''dangerous'' air. Furthermore, the cutoff point for ''dangerous'' air depends on the degree of immunosuppression of the exposed population and the exposure of deep tissues to the environment.
In our opinion, the reason for this information gap is clear. Systematic monitoring of concentrations of Aspergillus in the air of nonprotected hospital spaces is very uncommon, and when performed, it is usually undertaken late, once an ongoing epidemic outbreak has been demonstrated. This was not the case in our institution, where we routinely monitor levels and identification of filamentous fungi in the air of the MHS-ICU.
Newer techniques for real-time particle counting could prove faster than culture-based procedures when monitoring air quality. The use of particle counters could anticipate abnormally high peaks and thus make it possible to prevent new cases of IA. However, these procedures cannot identify fungi and should be carried out in parallel with culture-based procedures, at least when the peak has been detected [16] .
Although no conidia concentration above which the risk of increased incidence of IA has been established, our observations showed that air with a mean A. fumigatus load of $16.7 CFUs/m 3 should be considered ''dangerous'' when susceptible hosts are exposed. Recent guidelines from the Spanish Society for Infectious Diseases [16] suggest that nonfiltered air should not contain .5 conidia per cubic meter; other authors accept between 10 and 25 CFUs/m 3 [42, 43] . Concentrations of .25 CFUs/m 3 should be regarded as ''dangerous'' in the hospital setting [13] . In our institution, cases of IA disappeared briefly after air control measures were undertaken, although they subsequently recurred. The outbreak finished only when the MHS-ICU was closed for 1 month to install HEPA filters in all areas of the ICU. Since then, air surveillance monitoring has shown excellent air quality with an Aspergillus conidia load of ,5 CFUs/m 3 .
In our opinion, HEPA filtration should be implemented in MHS-ICUs and in ICUs that attend immunosuppressed patients. Environmental control measures must be reinforced when building work is in progress, and closure of the unit should be considered when an outbreak is declared.
One of the strengths of our study is that the isolates were collected prospectively, thus enabling us to genotype environmental and clinical isolates. Using a high-discriminatory molecular typing tool (STRAf), we found matches between environmental and clinical genotypes in 3 of the 6 patients with IA caused by A. fumigatus. Our study proved the epidemiological relationship between high concentrations of A. fumigatus spores in air and the appearance of cases of IA, as well as the presence of matches between patients and some of the environmental isolates.
Our results support environmental monitoring of Aspergillus spores in the air of postoperative units, even when these units receive nonimmunocompromised patients undergoing major surgery.
Notes
